High hopes for Snorekil in preventing long term ailments

WALES A new device called Snorekil has been undergoing a trial in hospitals, hoping to treat the millions of patients suffering from snoring, according to published reports.

Snoring, a problem that ails about 18 million people in the UK and 80 million people in the U.S., is often a symptom of sleep apnea, in which a person will stop breathing for periods of time while he or she is sleeping.

According to published reports, snoring—and apnea—has been linked to high blood pressure and heart attacks, as well as diabetes. The new device, invented by Paul Cattell, of Rhos-on-Sea, if deemed effective, will save the National Health Service millions of pounds in the treatments of heart related problems or other ailments.

Snorekil has already been piloted in Canada, Singapore and Thailand and is most recently being piloted in Wales, with the help of Catell’s wife, Marie, in manufacturing the new product. According to published reports they also have distributors in Switzerland and France, and are setting their sights on the Chinese market as well.

The gadget’s function is to fit inside the mouth and push the lower jaw forward, which then allows the airway to be cleared. At first their device cost 200 to 400 pounds, including a personal fitting, but after years of experimentation, Cattell has made the product adjustable and priced at just 50 pounds. The couple is hoping to get an approval by the Food and Drug Administration, relying on their award of Class One Medical Device status in Canada to help them do so.

Poll

Poll

Which of the current U.S. Presidential hopefuls do you think would be best for your business?

Hillary Clinton

Jeb Bush

Donald Trump

Ted Cruz

Ben Carson

Scott Walker

Marco Rubio

Rand Paul

Chris Christie

Mike Huckabee

SPECIAL REPORTS

Pharmacy’s battle for recognition continues

Fifty years ago this summer, President Lyndon B. Johnson secured his place in history by signing into law the legislation that created Medicare and Medicaid. To commemorate the anniversary, Drug Store News has put together an exclusive report on the effect that Medicare and Medicaid have had on the retail pharmacy industry and how it has transformed the role of the pharmacist. more...

IN THIS ISSUE

In this issue, DSN profiles Rite Aid and how the company is achieving a vision to become a retail healthcare company that delivers a higher level of care to its communities; takes you on a tour of Sears; offers insight into millennial shoppers and more. Click here to view the issue.